Biocryst Pharmaceuticals BCRX
NASDAQ BCRX
$8.17 +0.05 (+0.62%)
At close: Oct 2, 2026 · 4:00 PM EDT

Biocryst Pharmaceuticals (BCRX) Depreciation and Depletion (2025 - 2026)

Updated

Biocryst Pharmaceuticals' Depreciation and Depletion came in at $513,000 for Q2 2026, up 55.9% from $329,000 a year earlier and up 11.3% from the prior quarter.

Analysis

Biocryst Pharmaceuticals (BCRX) Depreciation and Depletion (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Biocryst Pharmaceuticals reported Depreciation and Depletion of $1.63 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 194.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 98.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Biocryst Pharmaceuticals 2.09 Bn 1.01 Bn 214.41 Mn 513,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 513,000.00
Mar 31, 2026 461,000.00
Jun 30, 2025 329,000.00
Mar 31, 2025 331,000.00
API Access

Biocryst Pharmaceuticals Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=BCRX&period=max&api_key=YOUR_API_KEY